Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


A candid look at the European drug regulatory network from a key player

This article was originally published in SRA

Executive Summary

In an exclusive interview with Scrip Regulatory Affairs, Jytte Lyngvig, a key player for many years in the European drug regulatory network and until recently head of the Danish Medicines Agency*, talks to Maureen Kenny about the future of the network and Denmark’s role in it, the EMA, transparency, adaptive licensing and the image of the pharmaceutical industry.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts